CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 78 enrolled
Drug / intervention
Bupivacaine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03292926
NCT03292926Phase 4Completed
CompareCT.gov

A Randomized Controlled Trial to Evaluate a Novel Analgesia Technique for ACL Reconstruction: Adductor Canal Block With an IPACK Versus Adductor Canal Block

Hospital for Special Surgery, New York·interventional·Posted Sep 26, 2017·Updated Sep 19, 2024

In Brief

A Phase 4 clinical trial evaluating Bupivacaine, Ultrasound, and 1 other intervention for Anterior Cruciate Ligament Injury. Completed, enrolled 78 participants across 1 site.

Detailed Summary

A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) reconstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnterior Cruciate Ligament Injury
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedSep 26, 2017
Enrollment StartOct 4, 2017
Primary CompletionMar 6, 2020
Study CompletionApr 16, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 8.8 years ago

Interventions

Bupivacainedrug

Bupivacaine will help treat pain and sensation after ACL repair

Ultrasounddevice

Ultrasound will guide anesthesiologist in performing the different nerve blocks

Dexamethasonedrug

Dexamethasone will be used to prolong block duration